Other

Biogen·Income Statement·106 metrics

Breakdown

Loading...

Metrics

Capital Expenditures

Tax Withholding for Share-Based Payments

Other Comprehensive Income (Loss), Net of Tax

OCI - Available-for-sale securities, net of tax

OCI - Cash flow hedge, net of tax

OCI - Defined benefit plan, net of tax

Other comprehensive income (loss), net of tax

Other Comprehensive Income (Loss)

Change in Income Taxes Payable

Change in Inventories

Effect of Exchange Rate on Cash (Continuing Operations)

Net Change in Cash and Restricted Cash

Value of Treasury Stock Reissued

OCI Cash Flow Hedge Gain (Loss)

OCI Net Unrealized Gain (Loss) on Securities

OCI Attributable to Parent

OCI Available for Sale Securities Adjustment

OCI Defined Benefit Plan Net of Tax

Unrealized Gains (Losses) on Hedge Instruments

Unrealized Gains on Available-for-Sale Securities

Number of reportable segments

Other comprehensive income (loss), after-tax

Other investing activities, net

Payments to acquire available-for-sale debt securities

OCI - Available-for-Sale Securities, Net of Tax

OCI - Cash Flow Hedges, Net of Tax

Share-based compensation expense related to employee stock plans

Adjustments To Product Revenue Reserves Relating To Sales In Prior Years

Share-Based Payment Arrangement, Expense, after Tax

Amortization and impairment of acquired intangible assets

Amortization of acquired inventory step-up

Collaboration profit sharing/(loss reimbursement)

Collaboration profit sharing/(loss reimbursement)

Comprehensive Income (Loss), Net of Tax, Attributable to Parent

Current Provisions Relating To Sales In Current Year

Deferred taxes

Depreciation

Effective tax rates

Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount

Share-Based Payment Arrangement, Expense, Tax Benefit

Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings

Gain (Loss), Foreign Currency Transaction, before Tax

Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments

Currency exchange and other

Income Tax Examination Estimate Of Possible Loss

Increase Decrease In Accrued Income Taxes Payable

Accrued liabilities

Increase (Decrease) in Inventories

Increase (Decrease) in Other Operating Assets and Liabilities, Net

Interest In Subsidiary

Cash Provided by (Used in) Financing Activity, Including Discontinued Operation

Cash Provided by (Used in) Investing Activity, Including Discontinued Operation

Cash Provided by (Used in) Operating Activity, Including Discontinued Operation

Number of reportable segments

Number of wholesalers

Other comprehensive income/(loss) before reclassifications

Lease impairment

Unrealized gains (losses) on available-for-sale securities

Unrealized gains (losses) on hedge instruments

Foreign currency translation gains (losses)

Other comprehensive income (loss)

Other comprehensive income/(loss)

Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax

Other Noncash Income (Expense)

Other income, net (Note 6)

Other income, net

Payment for (Proceeds from) Other Investing Activity

Payment, Tax Withholding, Share-Based Payment Arrangement

Payments Returns Applied Against Product Revenue Reserves Relating To Current Year

Payments Returns Applied Against Product Revenue Reserves Relating To Prior Year

Payments to Acquire Debt Securities, Available-for-Sale

Payments to acquire in process research and development

Payments to Acquire Intangible Assets

Payments to Acquire Property, Plant, and Equipment

Financing — other

Proceeds from maturities of marketable securities

(Purchases) refunds of spectrum licenses and other intangible assets, including deposits

Proceeds From Sale Of Other Investments

Gross realized gains (losses)

Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent

Reduction of research and development expense

Acquired in-process research and development, upfront and milestone expense

Research and development expense

Acquired in-process research and development, upfront and milestone expense

Stock-based compensation

Share-based compensation expense included in total cost and expense

Issuance of vested restricted stock units

Issuance of common stock and reissuance of treasury stock under equity incentive plans, net of forfeitures, value

Stockholders' Equity, Other

Unrealized gains

Unrealized Loss on Derivatives

Add: dilutive effect of potential common shares (in shares)

OCI Before Reclassifications, Net of Tax

Reclassification from AOCI, Net of Tax

Foreign Currency Translation Adjustment, Net of Tax

OCI Defined Benefit Plan, After Tax

Other Comprehensive Income (Loss)

OCI Pension Adjustments

OCI Available for Sale Securities Adjustment, Net of Tax

Other Comprehensive Income (Loss), Net of Tax, Attributable to Parent

OCI Net of Tax, Parent

OCI Pension Reclassification Adjustment, Pre-tax

OCI Unrealized Gain (Loss) on Securities, Pre-tax

OCI Attributable to Parent

OCI Defined Benefit Plan, Net of Tax

Stockholders' Equity, Other